Commonwealth Medicine, Clinical Pharmacy Services
Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Insurance | Pharmacoeconomics and Pharmaceutical Economics
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts.
rebates, drug prices, Department of Health and Human Services, Food and Drug Administration, price increases, generic competition
Rights and Permissions
© 2018 University of Massachusetts Medical School
Commonwealth Medicine Blog
Tran, Stephanie, "Will Removing Rebates Really Lower Drug List Prices?" (2018). Commonwealth Medicine Publications. 222.
Health Economics Commons, Health Law and Policy Commons, Health Policy Commons, Health Services Administration Commons, Health Services Research Commons, Insurance Commons, Pharmacoeconomics and Pharmaceutical Economics Commons